Table 1. Demographic characteristics.
| Surgery Group (n = 83) | Surgery+TACE Group (n = 83) | P–value | |
|---|---|---|---|
| Age (years) | 61.0 (36–83) | 57.0 (34–83) | 0.121 |
| Gender (Male) | 71 (85.5%) | 72 (86.7%) | 0.822 |
| BMI (kg/m2) | 23.9 (17.5–31.6) | 24.1 (16.2–32.2) | 0.612 |
| Serum HBV | 64 (77.1%) | 70 (84.3%) | 0.157 |
| Serum HCV | 1 (1.2%) | 0 (0%) | 1.000 |
| Hemoglobin (g/L) | 14.0 (8.0–17.1) | 14.3 (8.9–17.1) | 0.125 |
| ALT (IU/L) | 38.0 (7.0–128.0) | 36.0 (13.0–186.0) | 0.092 |
| Prothrombin Time (s) | 13.4 (11.5–17.3) | 13.5 (11.7–23.0) | 0.696 |
| Albumin (g/L) | 40.5 (28.2–51.0) | 41.8 (23.4–50.6) | 0.298 |
| Total Bilirubin (μmol/L) | 15.5 (3.2–50.7) | 14.8 (3.4–47.9) | 0.451 |
| Alpha–fetoprotein (ng/mL) | 14.7 (1.5–11408.0) | 22.8 (1.5–50500.0) | 0.743 |
| Child–Pugh Grade | 1.000 | ||
| A | 80 (96.4%) | 81 (97.6%) | |
| B | 3 (3.6%) | 2 (2.4%) | |
| Cirrhosis | 36 (43.4%) | 35 (42.2%) | 0.875 |
| HBV–related | 32 (38.6%) | 33 (39.8%) | 0.874 |
| HCV–related | 1 (1.2%) | 0 (0%) | 1.000 |
| Schistosome | 3 (3.6%) | 1 (1.2%) | 0.620 |
| Alcoholic | 0 (0%) | 1 (1.2%) | 1.000 |
| Family History of HCC | 8 (9.6%) | 13 (15.6%) | 0.243 |
Values are presented as median (range) or number (percentage). TACE, Transcatheter Arterial Chemoembolization; BMI, Body Mass Index; ALT, Alanine Aminotransferase; HBV, Hepatitis B virus; HCV, Hepatitis C virus; HCC, Hepatocellular Carcinoma.